Status:
UNKNOWN
Jejunal Feeding Via Gastrojejunal Tube in Refractory Gastroesophageal Reflux
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Gastroesophageal Reflux
Eligibility:
All Genders
1-18 years
Brief Summary
Gastroesophageal reflux disease (GERD) in children can be severe and lead to multiple complications, dizziness, esophagitis, respiratory failure or ENT infections. In the case of resistance to treatm...
Detailed Description
Gastroesophageal reflux disease (GERD) in children can be severe and lead to multiple complications, among them dizziness, esophagitis, respiratory failure or ENT infections. In the case of resistance...
Eligibility Criteria
Inclusion
- Children under 18
- Insertion of a gastro-jejunal tube with a goal of feeding by the jejunal route during GERD beyond 1/1/2000
- Follow-up\> 4 months.
- Follow-up at Robert-Debré hospital
Exclusion
- Refusal to participate in the study
- intra-gastric Gastro-jejunal tube placement, with the aim of gastric emptying
Key Trial Info
Start Date :
November 19 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 19 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05278689
Start Date
November 19 2021
End Date
November 19 2022
Last Update
March 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Robert Debré Hospital - Assistance Publique Hopitaux de Paris
Paris, France, 75019